HAPASIL SUSPENSION ORAL 50 mg/ml
  • Netobimin
  • Surrendered
Authorised in these countries:
  • Spain
Export to PDF

Product identification

Medicine name:
HAPASIL SUSPENSION ORAL 50 mg/ml
Active substance and strength:
  • Netobimin
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AC06
Authorisation number:
  • 241 ESP
Product identification number:
  • f0cc54c7-422f-4cbd-a4aa-55676bec47a0
Permanent identification number:
  • 600000058887

Product details

Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Sheep
      • Meat and offal
        6
        day
      • Milk
        5
        day

Availability

Package description:
Manufacturing sites for batch release:
  • Trirx Segre
Source wholesaler:
This information is not available for this product.
Destination wholesaler:
This information is not available for this product.

Authorisation details

Authorisation status:
  • Surrendered
Authorisation procedure type:
  • Marketing Authorisation
Procedure number:
  • 241 ESP
Date of authorisation status change:
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Authorisation country:
  • Spain
Responsible authority:
  • (AEMPS)
Marketing authorisation holder:
  • Merck Sharp & Dohme Animal Health S.L.
Marketing authorisation issued:
Reference member state:
This information is not available for this product.
Concerned member states:
This information is not available for this product.
Reference product identifier:
This information is not available for this product.
Source product identifier:
This information is not available for this product.

Additional information

To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet

Documents

Summary of Product Characteristics (PDF)
First published:
Last updated:
Labelling (PDF)
First published:
Last updated:
Package Leaflet (PDF)
First published:
Last updated:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."